Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar;47(3):430-8.
doi: 10.1038/bmt.2011.137. Epub 2011 Jun 27.

Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients

Affiliations
Free PMC article

Endoscopic diagnosis of acute intestinal GVHD following allogeneic hematopoietic SCT: a retrospective analysis in 175 patients

W Kreisel et al. Bone Marrow Transplant. 2012 Mar.
Free PMC article

Abstract

Diagnosis of acute intestinal GVHD (aGVHD) following allogeneic hematopoietic cell transplantation is based on clinical symptoms and histological lesions. This retrospective analysis aimed to validate the 'Freiburg Criteria' for the endoscopic grading of intestinal aGVHD. Grade 1: no clear-cut criteria; grade 2: spotted erythema; grade 3: aphthous lesions; and grade 4: confluent defects, ulcers, denudation of the mucosa. Having excluded patients with infectious diarrhea, we evaluated 175 consecutive patients between January 2001 and June 2009. Setting a cutoff between grade 1 (no change in therapy) and grade 2 (intensification of immunosuppression), macroscopy had a sensitivity of 89.2% (95% confidence interval (CI): 80.4-94.9%), a specificity of 79.4% (95% CI: 69.6-87.1%), a positive-predictive value of 79.6% (95% CI: 70.0-87.2%) and a negative-predictive value of 89.0% (95% CI: 80.2-94.9%). In all, 20% of patients with aGVHD in the lower gastrointestinal tract (GIT) had lesions only in the terminal ileum. In all patients with aGVHD ≥2 of the upper GIT, typical lesions were also found in the lower GIT. Ileo-colonoscopy showed the highest diagnostic yield for aGVHD. In conclusion, the 'Freiburg Criteria' for macroscopic diagnosis of intestinal aGVHD provide high accuracy for identifying aGVHD ≥2.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Time interval between SCT and endoscopy.
Figure 2
Figure 2
Histological findings in different grades of intestinal aGVHD. Apoptotic crypt cell loss (grade 1) or loss of single crypts (grade 2) are marked by arrows. Grade 3: loss of contiguous crypts (white ellipse). Grade 4: complete denudation of the mucosa.
Figure 3
Figure 3
(a) Examples for macroscopic grading of aGVHD as grade 2. (b) Examples for macroscopic grading of aGVHD as grade 3. (c) Examples for macroscopic grading of aGVHD as grade 4: Confluent defects, ulcerations and complete denudation of the mucosa. The white flap is sloughed mucosa.
Figure 4
Figure 4
Distribution of different grades of aGVHD in the gastrointestinal tract. Frequency of histological grading of intestinal aGVHD in the different parts of the gastrointestinal tract. Term. ileum, terminal ileum.
Figure 5
Figure 5
Diagnostic yield of histology of different parts of the gastrointestinal tract. (a) Only colonoscopy vs colonoscopy+ileoscopy. Number of patients with histologically proven aGVHD ⩾1 in: only colon; colon and terminal ileum; and only terminal ileum. Number of patients with histologically proven aGVHD ⩾2 in: only colon; colon and terminal ileum; only terminal ileum. (b) Ileo-colonoscopy vs upper GIT endoscopy vs combination of both. Number of patients with histologically proven aGVHD ⩾1 in: only lower GIT; lower and upper GIT; and only upper GIT. Number of patients with histologically proven aGVHD ⩾2 in: only lower GIT; lower and upper GIT; and only upper GIT. Term. ileum, terminal ileum.

Comment in

Similar articles

Cited by

References

    1. Jenq RR, van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer. 2010;10:213–221. - PubMed
    1. Prasad VK, Kurtzberg J. Transplant outcomes in mucopolysaccharidoses. Semin Hematol. 2010;47:59–69. - PubMed
    1. Hough R, Rocha V. Transplant outcomes in acute leukemia II. Semin Hematol. 2010;47:51–58. - PubMed
    1. MacMillan ML, Walters MC, Gluckman E. Transplant outcomes in bone marrow failure syndromes and hemoglobinopathies. Semin Hematol. 2010;47:37–45. - PubMed
    1. Kohn DB. Update on gene therapy for immunodeficiencies. Clin Immunol. 2010;135:247–254. - PMC - PubMed

MeSH terms